Saudi sources describe progress on making semaglutide locally, while Novo says only that it is exploring opportunities and gives no timeline.
Recap by typeshit. Full story at MedWatch.
Beauty companies are reportedly exploring products aimed at facial volume loss in people who have lost weight on GLP-1 drugs.
A short Fox16 social clip points to GLP-1 users shifting how they drink when they go out, with the full story linked in the station's bio.
A Facebook share points to shifting drinking habits in pubs and bars as more people take GLP-1 medications, with the full story linked.
Food Dive reports the Atkins brand is shifting its pitch toward lapsed GLP-1 users, a growing group food companies are now chasing.
As more people stop taking GLP-1 drugs, Grocery Dive asks how supermarkets plan to serve shoppers whose appetites and habits shift again.
The new ACOG practice advisory cites thin safety data and also urges caution while breastfeeding, especially with preterm and newborn infants.
Loading…